Find the latest pharmaceutical market place for formulations enquiry about Desvenlafaxine Succinate on PharmaCompass.com.

In-Licensing of Various FDFs needed in France [ENA23716]

A company focused on the development and manufacturing of a wide range of products is looking for the in-licensing of various FDFs. The supplier must support this enquiry with the EU-CTD dossiers.
1. Desvenlafaxine (50 mg or 100 mg) Tablets
2. Rifamycin 1% Solution for Topical
3. Lidocaine HCL (50mg/ 5 ml) Ampoule
4. Pentamidine (300 mg/ ml) Vial

Reply

07 Aug 2025

Various Finished Dosage Formulations needed in Brazil [ENA12623]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with CTD Dossier, ANVISA, DMF & PIC/s GMP.
1. Quetiapine Fumarate (25 mg, 100 mg & 200 mg) Coated Tablets. The required quantity is 8 million units, 4 million units & 1 million units respectively.
2. Venlafaxine (75 mg, 50 mg & 100 mg) Tablets. The required quantity is 2 million units, 30 million units & 20 million units respectively.
3. Venlafaxine (50 mg & 100 mg) Control Release Tablets. The required quantity is 10 million units for each.
4. Venlafaxine (75 mg, 150 mg & 37.5 mg) Slow Release Capsules. The required quantity is 65 million units, 90 million units & 10 million units respectively.
5. Desvenlafaxine (50 mg & 100 mg) Slow Release Tablets. The required quantity is 65 million units & 60 million units respectively.
6. Empagliflozin (25 mg & 10 mg) Coated Tablets. The required quantity is 100 million units & 10 million units respectively.

Reply

07 Feb 2022